Article Details

Monoclonal Antibody Therapy Cuts Death Risk in COVID-19 Patients by 20%

Retrieved on: 2021-06-16 15:51:13

Tags for this article:

Click the tags to see associated articles and topics

Monoclonal Antibody Therapy Cuts Death Risk in COVID-19 Patients by 20%. View article details on hiswai:

Excerpt

Treatment with the therapy, which is a combination of two monoclonal antibodies -- Casirivimab and Imdevimab -- was touted as a game changer with ...

Article found on: www.latestly.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo